Retrospective analysis of preventable procedural adverse events (ICD-10 Y62-Y69) in the TriNetX network: a multiregional study before, during and after the COVID-19 pandemic. [PDF]
Caruso R +12 more
europepmc +1 more source
Background Epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR‐TKIs) have substantially improved outcomes in non‐small cell lung cancer (NSCLC); however, the development of treatment resistance remains a major clinical challenge. This study examines the association between concomitant prescriptions of H1‐antihistamines (H1AHs) and ...
Van Thuan Nguyen +10 more
wiley +1 more source
Nationwide trends and demographic projections of hospitalisations for vertebral fractures and postmenopausal osteoporosis in Germany: a 24-year registry-based study. [PDF]
Anees H +4 more
europepmc +1 more source
Aims Almost 5% of pregnancies are affected by immune‐mediated inflammatory diseases (IMIDs). As treatments become available, understanding their use during pregnancy is important. We aimed to describe maternal, pregnancy and infant outcomes among IMID pregnancies exposed to biologic therapies. Methods Using the Merative™ MarketScan® Commercial Database,
Leah K. Flatman +3 more
wiley +1 more source
Aims The purpose of this study is to evaluate efficacy, safety and mental‐health outcomes of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in adults with overweight or obesity and antipsychotic‐treated schizophrenia‐spectrum disorders. Methods PubMed/MEDLINE, Embase, PsycINFO, CENTRAL, Virtual Health Library (VHL) (Biblioteca Virtual em Saúde, BVS),
Débora Regina de Aguiar +10 more
wiley +1 more source
Identification of Patients with Colon Ischemia in the Swedish ESPRESSO Cohort: A Validation Study. [PDF]
Klinglöf H +6 more
europepmc +1 more source
A case for the introduction of the ICD-11 in Germany. [PDF]
Stausberg J +3 more
europepmc +1 more source
Athletes with Implantable Cardioverter-Defibrillators: A Practical Framework for Device Selection, Programming, and Return-to-Sport Risk Mitigation. [PDF]
Sharp Dimitri D, Prutkin JM.
europepmc +1 more source
Antibody-drug conjugates and immunogenic cell death in breast cancer: agent-specific mechanisms, clinical evidence and translational priorities. [PDF]
Fang L, Song J, Wang X, Wang F, Zhu X.
europepmc +1 more source

